Neurobiology and Clinical Neuroscience
A section of Biomedicines (ISSN 2227-9059).
Section Information
This section publishes reviews and original peer-reviewed papers of a high scientific level covering all aspects of the treatment of neurobiology and neurologic diseases. Topics include, but are not limited to neurogenesis, neuroplasticity, neuropharmacology, and neurotherapeutics, in vitro and in vivo responses to neurological diseases, identification of therapeutic targets, evaluation of diagnostic markers, and assessment of therapies for neurological disorders.
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Autonomic Dysfunction in Neurological Disorders: Novel Mechanisms and Targets (Deadline: 31 July 2025)
- Glioblastoma: From Pathology to Novel Therapeutic Approaches (Deadline: 31 July 2025)
- Animal Models of Neurological Disorders: Where Are We Now? (3rd Edition) (Deadline: 31 July 2025)
- Advances of Amyloid-β Dynamics in Health and Diseases (Deadline: 31 July 2025)
- Cellular and Molecular Biology of Neurodegenerative Disorders (Deadline: 31 July 2025)
- Recent Advances in Craniofacial Pain and Headaches—Second Edition (Deadline: 31 July 2025)
- State-of-the-Art Pain Medicine (Deadline: 31 July 2025)
- Neurodegeneration in Cognitive Impairment and Mood Disorders for Experimental, Clinical, and Translational Neuropsychiatry—Second Edition (Deadline: 31 July 2025)
- Advanced in Schizophrenia Research and Treatment (Deadline: 31 July 2025)
- Biomedical and Biochemical Basis of Neurodegenerative Diseases (Deadline: 31 August 2025)
- Mechanisms and Novel Therapeutic Approaches for Neurodegenerative Diseases (2nd Edition) (Deadline: 31 August 2025)
- Advancements in Brain Diagnosis and Treatment: From Insights to Innovations (Deadline: 31 August 2025)
- Multiple Sclerosis: Diagnosis and Treatment—3rd Edition (Deadline: 31 August 2025)
- Neurodegenerative Diseases: From Mechanisms to Therapeutic Approaches, 2nd Edition (Deadline: 31 August 2025)
- Brain Imaging and Cognitive Deficits in Psychiatric Disorders, 2nd Edition (Deadline: 31 August 2025)
- Mitochondrial Dysfunction and Oxidative Stress (Deadline: 31 August 2025)
- Neuroendocrine Neoplasia and Endocrine Tumors: Pathogenic Features, Prognostic Markers and New Therapeutic Approaches (Deadline: 31 August 2025)
- Neuromuscular Diseases: Biochemical, Genetic, and Electrophysiological Studies (Deadline: 30 September 2025)
- Medical Imaging in Brain Tumor: Charting the Future (Deadline: 30 September 2025)
- Epilepsy: Pathomechanism, Diagnostics, and Novel Treatment Options (Deadline: 30 September 2025)
- Neuroscience Through Electrophysiology: Current Trends and Future Directions (Deadline: 30 September 2025)
- Advances in Stroke Neuroprotection and Repair (Deadline: 30 September 2025)
- Advanced Molecular Mechanisms and Treatment of Neurological Diseases (Deadline: 30 September 2025)
- Molecular Characteristics of Cerebral Ischemia and Their Therapeutic Applications (Deadline: 30 September 2025)
- Neurodevelopmental Disorders: From Pathophysiology to Novel Therapeutic Approaches—2nd Edition (Deadline: 30 September 2025)
- Advancements in Neuroscience: A Special Issue in Honour of Ramón Y Cajal (Deadline: 30 September 2025)
- Cell Signaling and Molecular Regulation in Neurodegenerative Disease (Deadline: 31 October 2025)
- The Intricacies of Developmental and Epileptic Encephalopathies: A Journey Towards Innovative Therapies (Deadline: 31 October 2025)
- Protein Misfolding and Functional Impairment in Neurodegenerative Diseases (Deadline: 31 October 2025)
- Dualistic Equilibrium in Neurotransmission and Beyond: Unraveling the Pathophysiology and Unlocking Novel Therapeutic Targets in Neuropsychiatric Disorders—2nd Edition (Deadline: 31 October 2025)
- Diagnostic Biomarkers and Novel Therapeutics Targets for Fragile X Syndrome, Autism Spectrum Disorders and Genetic Neurodevelopmental Diseases: Advances and Challenges, 2nd Edition (Deadline: 31 October 2025)
- PET and SPECT Imaging for the Diagnosis of Neurodegenerative Diseases (Deadline: 31 October 2025)
- Emerging Therapeutic Strategies for Epilepsy: Bridging Research and Clinical Practice (Deadline: 31 October 2025)
- New Molecular Insights into the Pathogenesis and Drug Development of Neurodegenerative Diseases: 2nd Edition (Deadline: 31 October 2025)
- Neurodevelopmental Disorders: From Mechanisms to Therapeutic Approaches (Deadline: 31 October 2025)
- Spinal Muscular Atrophy: Pathogenesis, Diagnosis, Therapeutics and Future Directions (Deadline: 15 November 2025)
- The Interplay Between miRNA and Mitochondrial Dysfunction in Neurodegenerative Diseases (Deadline: 30 November 2025)
- Neuroinflammation and Neuroprotection (Deadline: 30 November 2025)
- Progress in Neurodevelopmental Disorders Research (Deadline: 30 November 2025)
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management—2nd Edition (Deadline: 30 November 2025)
- Advances in Neurophysiology and the Treatment of Parkinson’s Disease (Deadline: 30 November 2025)
- Biomarkers for Neurodegenerative Disorders: From Bench to Bedside (Deadline: 30 November 2025)
- Molecular Research of Neurological and Psychiatric Disorders (Deadline: 30 November 2025)
- Mechanisms and Therapeutic Strategies of Brain and Spinal Cord Injury (Deadline: 30 November 2025)
- Molecular and Histopathological Background of Diabetic Neuropathy (Deadline: 30 November 2025)
- Exploring Neuroinflammation in Central and Peripheral Neuropathic Pain and Related Disorders (Deadline: 31 December 2025)
- Gene- and Peptide-Based Therapeutics for Neurodegenerative Disorders (Deadline: 31 December 2025)
- State-of-the-Art Neurobiology and Clinical Neuroscience in the United States (Deadline: 31 December 2025)
- Pathogenesis and Therapeutic Intervention of Alzheimer's Disease (Deadline: 31 December 2025)
- Neuromuscular Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 December 2025)
- Recent Therapeutic Advances in Parkinson’s Disease (Deadline: 31 December 2025)
- Advanced Research in Neuroprotection (Deadline: 31 December 2025)
- Advances in Neurological Diseases: Pathogenesis, Diagnosis and Therapeutic Strategies (Deadline: 31 December 2025)
- Challenges in the Diagnosis and Treatment of Parkinson’s Disease (Deadline: 31 December 2025)
- Traumatic CNS Injury: From Bench to Bedside (2nd Edition) (Deadline: 31 December 2025)
- Nanomedicine Applications in the Diagnosis and Treatment of Neurodegenerative Diseases (Deadline: 31 December 2025)
- Neurotransmitters in Health and Diseases (Deadline: 31 December 2025)
- Inflammation in Neurogenerative Diseases: Mechanisms and Therapeutic Frontiers (Deadline: 1 January 2026)
- New Advances in Neuroprotective Agent (Deadline: 31 January 2026)
- Cell Metabolism in Brain Physiology and Pathology: From Molecular Mechanisms to Therapeutic Targets (Deadline: 31 January 2026)
- Emerging Technologies in the Diagnosis and Management of Neurological Disorders (Deadline: 31 January 2026)
- The Prefrontal Cortex in Cognition and Diseases (Deadline: 31 January 2026)
- Nervous System Diseases: From Pathophysiology to Novel Therapeutic Approaches (Deadline: 31 January 2026)
- Molecular Research of Neurodegenerative and Psychiatric Diseases, 2nd Edition (Deadline: 31 January 2026)
- Molecular Mechanisms and Novel Therapies for Brain Injury: 2nd Edition (Deadline: 31 January 2026)
- Neurovascular Dysfunction: Mechanisms and Therapeutic Strategies (Deadline: 31 January 2026)
- New Advances in Epilepsy Research (Deadline: 31 January 2026)
- Parkinson’s Disease: Where Are We and Where Are We Going To (Deadline: 31 January 2026)
- Brain Injury: New Insights into Mechanisms and Future Promising Treatments—Second Edition (Deadline: 31 January 2026)
- Neural Nexus: Interdisciplinary Perspectives on Neurological Disorders (Deadline: 31 January 2026)
- Neural Organoids: Advancing Our Understanding of the Central and Peripheral Nervous Systems (Deadline: 31 January 2026)
- Emerging Research in Neurorehabilitation, 2nd Edition (Deadline: 31 January 2026)
- Neurotrauma: Mechanisms, Pathways, and Emerging Therapeutic Interventions, 2nd Edition (Deadline: 28 February 2026)
- Nervous System Injury and Repair: From Molecular Mechanism to Therapeutic Perspectives (Deadline: 28 February 2026)
- Current Challenges and Future Trends in Intracranial Aneurysms: Mechanisms, Biomarkers, and Therapeutic Strategies (Deadline: 28 February 2026)
- Immune and Metabolic Dysregulation in Neurological and Neuropsychiatric Disorders (Deadline: 28 February 2026)
- Glioblastoma: Pathogenetic, Diagnostic and Therapeutic Perspectives (Deadline: 28 February 2026)
- Multidisciplinary Approaches to Neurodegenerative Disorders (Deadline: 28 February 2026)
- Demyelinating Diseases: Pathophysiology and Emerging Therapeutic Targets (Deadline: 28 February 2026)
- New Approaches to Spinal Cord-Related Diseases (Deadline: 31 March 2026)
- Fibromyalgia and Neuroinflammation: Unraveling Pathophysiological Links and Therapeutic Targets (Deadline: 31 March 2026)
- Imaging and Modeling Alzheimer's Disease: The Quest for Mechanistic Understanding, Early Diagnosis, and Novel Treatments (Deadline: 31 March 2026)
Topical Collections
Following topical collections within this section are currently open for submissions:
- Feature Papers in Neuromodulation and Brain Stimulation
- Nervous System Inflammation
- Neurodegeneration No More: Cutting-Edge Technologies and Therapies in the Evolution of Neurodegenerative Disease Management
- Neurodevelopmental Disorders: From Pathophysiology to Treatment
- Neurogenic Neuroinflammation in Fibromyalgia
- Neurotoxicity: Mechanisms and Potential Therapeutic Strategies (Closed)
- Preclinical Breakthroughs to Clinical Frontiers: Translating Molecular Psychiatry
